In this podcast, Peter Henke, MD, talks about his recent session at the 2021 VEITHsymposium, during which he talked about the research supporting newer direct oral anticoagulation (DOAC) therapies, the future of research, and which patients should receive DOACs after lower extremity bypass surgery.

William Schaffner, MD, on Vaccination Recommendations and Strategies for Implementation by Consultant360

In this podcast, Saad Z. Usmani, MD, MBA, speaks about the efficacy of daratumumab, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma and impaired renal function from the phase 3 Maia Study based on Lenalidomide starting dose. He also presented on this topic at the 63rd ASH Annual Meeting & Exposition.

In this podcast, Nirmish Shah, MD, speaks about real-world experience of voxelotor for the management of complications in sickle cell disease, including if voxelator helps improve hemoglobin. He also presented on this topic at the 63rd ASH Annual Meeting & Exposition.

In this podcast, Rohan Henry, MD, MS, speaks about childhood growth hormone deficiency, including how the diagnostic criteria have evolved over time and the ethical implications of diagnosis.

In this podcast, Isaac Nichols, PharmD, speaks about the appropriateness of direct oral anticoagulation prescribing for new-onset venous thromboembolism and nonvalvular atrial fibrillation, specifically the Xa inhibitors, rivaroxaban and apixaban. He presented on this topic at ASHP Midyear 2021.

In this podcast, Mary Looby, PharmD, and Christopher S. King, MD, speak about the use of direct oral anticoagulants for the treatment of venous thromboembolic disease and the duration of anticoagulation following pulmonary embolism. They also presented on these topics at CHEST 2021 Annual Meeting.

In this podcast, Robert Klein, DPM, CWS, speaks about the prevalence of diabetic-related foot ulcer, recurrence, infection, and amputation among people with diabetes, the 5-year mortality of diabetic foot complications compared with cancer, and the economic burden of diabetic foot complications.

In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, speaks about how gender modifies the effect of rheumatoid arthritis on all-cause mortality and why rheumatoid arthritis is underdiagnosed.

In this podcast, George Tetz, MD, PhD; Danai Khemasuwan, MD, FCCP; Timothy Schwarz, DO; and Asim Kichloo, MD, discuss their respective studies recently presented at CHEST 2021 under the topic "New Insights and Approaches to Management of Severe Pneumonia and Its Complications."